Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene

被引:30
作者
Peppa, Melpomeni [1 ]
Boutati, Eleni [2 ]
Kamakari, Smaragda [3 ]
Pikounis, Vasilios [1 ]
Peros, George
Panayiotides, Ioannis G. [4 ]
Economopoulos, Theofanis [2 ]
Raptis, Sotirios A. [2 ,5 ]
Hadjidakis, Dimitrios [1 ]
机构
[1] Univ Athens, Sch Med, Endocrine Unit, Res Inst, Athens 12462, Greece
[2] Univ Athens, Sch Med, Dept Internal Med Propaedeut 2, Res Inst, Athens 12462, Greece
[3] Ctr Genet Res & Anal, Athens, Greece
[4] Univ Athens, Sch Med, Dept Pathol 2, Attikon Univ Hosp, Athens 12462, Greece
[5] Attikon Univ Hosp, Hellen Natl Diabet Ctr, Athens, Greece
关键词
D O I
10.1530/EJE-08-0476
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Multiple endocrine neoplasia type 2A (MEN2A) is an autosomal domin ant hereditary disorder, associated with a cluster of germline gain-of-function mutations of the RET proto-oncogene (RET), mainly in exons 10-15. The G533C mutation in exon 8 of the RET is rare and has been mainly related to the familial medullary thyroid carcinoma. Patients-methods: We describe the RET G533C mutation in exon 8 of the RET in two unrelated female index patients, with MEN2A phenotype, consisting of pheochromocytoma which was the presenting feature and medullary thyroid carcinoma. In addition, 12 family members were also studied. DNA extraction, PCR, and sequencing of RET was performed in exons 7-19 and 21, following standard procedures. Results: The mutation was found in both index patients and in 6 out of 12 family members (50%). Three of them were biochemically affected with histologically proven medullary thyroid carcinoma in two of them while there are no certain clues regarding the other three members as they declined further evaluation. Conclusion: Patients with MEN2A should be also searched in exon 8 while positive carriers of this mutation should be screened annually for pheochromocytoma or other components of the syndrome.
引用
收藏
页码:767 / 771
页数:5
相关论文
共 23 条
  • [1] Alevizaki M, 2006, THYROID CANC THESSAL, P395
  • [2] Polymorphisms in Exon 13 and intron 14 of the RET protooncogene:: Genetic modifiers of medullary thyroid carcinoma?
    Baumgartner-Parzer, SM
    Lang, R
    Wagner, L
    Heinze, G
    Niederle, B
    Kaserer, K
    Waldhäusl, W
    Vierhapper, H
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (11) : 6232 - 6236
  • [3] A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A
    Berndt, I
    Reuter, M
    Saller, B
    Frank-Raue, K
    Groth, P
    Grussendorf, M
    Raue, F
    Ritter, MM
    Höppner, W
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03) : 770 - 774
  • [4] Bethanis Sotirios, 2007, Hormones (Athens), V6, P152
  • [5] Guidelines for diagnosis and therapy of MEN type 1 and type 2
    Brandi, ML
    Gagel, RF
    Angeli, A
    Bilezikian, JP
    Beck-Peccoz, P
    Bordi, C
    Conte-Devolx, B
    Falchetti, A
    Gheri, RG
    Libroia, A
    Lips, CJM
    Lombardi, G
    Mannelli, M
    Pacini, F
    Pondder, BAJ
    Raue, F
    Skogseid, B
    Tamburrano, G
    Thakker, RV
    Thompson, NW
    Tomassetti, P
    Tonelli, F
    Wells, SA
    Marx, SJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (12) : 5658 - 5671
  • [6] A novel germ-line point mutation in RET exon 8 (Gly533Cys) in a large kindred with familial medullary thyroid carcinoma
    Da Silva, AMA
    Maciel, RMB
    Da Silva, MRD
    Toledo, SRC
    De Carvalho, MB
    Cerutti, JM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (11) : 5438 - 5443
  • [7] RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors
    de Groot, Jan Willem B.
    Links, Thera P.
    Plukker, John T. M.
    Lips, Cornelis J. M.
    Hofstra, Robert M. W.
    [J]. ENDOCRINE REVIEWS, 2006, 27 (05) : 535 - 560
  • [8] MUTATIONS IN THE RET PROTOONCOGENE ARE ASSOCIATED WITH MEN 2A AND FMTC
    DONISKELLER, H
    DOU, SS
    CHI, D
    CARLSON, KM
    TOSHIMA, K
    LAIRMORE, TC
    HOWE, JR
    MOLEY, JF
    GOODFELLOW, P
    WELLS, SA
    [J]. HUMAN MOLECULAR GENETICS, 1993, 2 (07) : 851 - 856
  • [9] The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2 - International RET mutation consortium analysis
    Eng, C
    Clayton, D
    Schuffenecker, I
    Lenoir, G
    Cote, G
    Gagel, RF
    vanAmstel, HKP
    Lips, CJM
    Nishisho, I
    Takai, SI
    Marsh, DJ
    Robinson, BG
    FrankRaue, K
    Raue, F
    Xue, FY
    Noll, WW
    Romei, C
    Pacini, F
    Fink, M
    Niederle, B
    Zedenius, J
    Nordenskjold, M
    Komminoth, P
    Hendy, GN
    Gharib, H
    Thibodeau, SN
    Lacroix, A
    Frilling, A
    Ponder, BAJ
    Mulligan, LM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (19): : 1575 - 1579
  • [10] Screening of six risk exons of the RET proto-oncogene in families with medullary thyroid carcinoma in the Czech Republic
    Jindrichová, S
    Vcelák, J
    Vlcek, P
    Neradilová, M
    Nemec, J
    Bendlová, B
    [J]. JOURNAL OF ENDOCRINOLOGY, 2004, 183 (02) : 257 - 265